Sanofi (SNY) Amortization - Intangibles (2009 - 2026)

Sanofi has reported Amortization - Intangibles for 18 years, with the latest figure at -$1.2 billion in Q2 2026.

• Quarterly Amortization - Intangibles fell 35.59% year-over-year to -$1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.3 billion (down 197.71% YoY) and the FY2025 annual result came in at $2.1 billion, up 10.61% from the prior year.
• Amortization - Intangibles declined to -$1.2 billion in Q2 2026 per SNY's latest filing, from -$110.1 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at -$26.3 million in Q1 2025 and troughed at -$2.6 billion in Q4 2025.
• A 5-year average of -$869.3 million and a median of -$560.2 million in 2023 frame the typical range for Amortization - Intangibles.
• The widest YoY moves for Amortization - Intangibles: up 95.0% in 2025, down 456.07% in 2025.
• Over 5 years, Amortization - Intangibles stood at -$2.1 billion in 2022, then advanced by 1.84% to -$2.1 billion in 2023, then soared by 77.18% to -$469.1 million in 2024, then sank by 456.07% to -$2.6 billion in 2025, then surged by 55.75% to -$1.2 billion in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered -$1.2 billion, -$110.1 million, and -$2.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.